227199-51-1

Basic information

• Product Name: Benzenemethanamine, 2-(1-methylethoxy)- (9CI)
• Synonyms: Benzenemethanamine, 2-(1-methylethoxy)- (9CI);(2-Isopropoxyphenyl)methylamine;(2-Isopropoxyphenyl)methylamine, {[2-(Prop-2-yl)oxy]phenyl}methylamine;BenzeneMethanaMine, 2-(1-Methylethoxy)-;(2-Isopropoxyphenyl)
• CAS NO: 227199-51-1
• Molecular Formula: C10H15NO
• Molecular Weight: 165.2322
• Product Categories: METHOXY
• Mol File: 227199-51-1.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 53-56°C/0.07mm
• Flash Point: 98.9°C
• Appearance: /
• Density: 0.99g/cm³
• Vapor Pressure: 0.0254mmHg at 25°C
• Refractive Index: 1.518
• Storage Temp.: 2-8°C
• CAS DataBase Reference: Benzenemethanamine, 2-(1-methylethoxy)- (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Benzenemethanamine, 2-(1-methylethoxy)- (9CI)(227199-51-1)
• EPA Substance Registry System: Benzenemethanamine, 2-(1-methylethoxy)- (9CI)(227199-51-1)

Safety Data

• Hazard Codes: Xi
• Hazardous Substances Data: 227199-51-1(Hazardous Substances Data)

Usage

General Description

Benzenemethanamine, 2-(1-methylethoxy)- (9CI) is a chemical compound that is also known as N-(2-methoxyethyl)aniline. It is an organic compound with the molecular formula C9H13NO and the IUPAC name 2-(2-methoxyethyl)aniline. This chemical is used in the production of medications and dyes, as well as in the synthesis of various organic compounds. It is classified as an amine, which is a type of organic compound that contains a basic nitrogen atom. Benzenemethanamine, 2-(1-methylethoxy)- (9CI) is also used in the synthesis of pharmaceuticals and as a building block for other organic molecules.

InChI:InChI=1/C10H15NO/c1-8(2)12-10-6-4-3-5-9(10)7-11/h3-6,8H,7,11H2,1-2H3

Upstream product

• 90921-35-0 2-isopropoxybenzonitrile 
• 22921-58-0 2-isopropoxybenzaldehyde 
• 90-02-8 salicylaldehyde 
• 611-20-1 salicylonitrile 

Downstream Products

• 1235889-61-8 C₁₇H₁₉NO 

Relevant articles and documents

SUBSTITUTED HETEROCYCLIC AMIDE COMPOUND AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF

Provided are a substituted heterocyclic amide compound having a selective inhibitory effect on RIPK1, and a pharmaceutically acceptable salt, a stereoisomer, a solvate or a prodrug thereof, and a pharmaceutical composition containing the compound, and the

Modulators of protease activated receptors

The present invention provides novel compounds of the Formula (I), pharmaceutical compositions comprising such compounds and methods for using such compounds as tools for biological studies or as agents or drugs for therapies such as metabolic syndrome, obesity, type II diabetes, fibrosis and cardiovascular diseases, whether they are used alone or in combination with other treatment modalities.

Dynamic kinetic asymmetric synthesis of substituted pyrrolidines from racemic cyclopropanes and aldimines: Reaction development and mechanistic insights

An enantioselective preparation of 2,5-cis-disubstituted pyrrolidines has been achieved via a dynamic kinetic asymmetric transformation (DyKAT) of racemic donor-acceptor cyclopropanes and (E)-aldimines. Mechanistic studies suggest that isomerization of the aldimine or resultant iminium to the Z geometry is not a pathway that furnishes the observed 2,5-cis-disubstituted products.